Careers Investor Relations Education & Training Portal Logins CONTACT PRODUCTS & SERVICES THERAPEUTIC AREAS CUSTOMER SUPPORT ABOUT US Who We Are Our Inspiration Locations Corporate Social Responsibility Humane Care Initiative Eureka Science Community Investor Relations News & Events Careers News & Events News & Events Featured Stories Media Coverage Press Releases Conferences Press Resources Media Coverage Why this crab's blood could save your life 09/04/2014 Nearly 50 years ago, scientists discovered the horseshoe crab's clotting response to bacterial toxins. Now, its blood is harvested in huge quantities to be used in a test to ensure medical products are not contaminated. James Foster Interview on Mad Money with Jim Cramer 08/15/2014 Mad Money host Jim Cramer speaks with James Foster about the Company’s Q2 earnings and why the work we do is so important. An ancient animal's blood is a modern medical miracle 06/17/2014 At a facility on the outskirts of Charleston, South Carolina, Charles River Endosafe® extracts the blood from horseshoe crabs. Charles River is one of four companies in the US that utilize horseshoe crabs’ blood to manufacture Limulus Amebocyte Lysate (LAL), which is used for the detection and quantification of bacterial endotoxins. Protecting an Ancient Mariner 06/09/2014 Limulus amebocyte lysate (LAL), a reagent that utilizes clotting enzymes extracted from horseshoe crab blood, is among the most accurate and reliable indicators of bacteria. Charles River continues to serve as an advocate for the optimal usage of LAL and conservation of this creature. What's Old Is New Again - A Prescription for Drug Repurposing 05/28/2014 Many pharmaceutical companies are salvaging failed compounds and seeing whether these drugs might have other indications, particularly after an increasing number of previously shelved compounds have been repurposed. Opinion: Pairing Discovery with Regulatory Rigor 05/13/2014 To move cell-based therapies into the clinic, academic researchers may benefit by consulting researchers outside of academia and the biopharma industry. Five Ways to Improve Host-Cell Protein Assay Performance 05/02/2014 Arguably, the biggest challenge in making biologics is flagging unwanted host-cell proteins (HCPs) that inevitably show up in the finished product. While nano in scale, these trace amounts can be highly immunogenic and can ultimately sink a potential biopharmaceutical. As a result, manufacturers must work hard to identify and control any impurities in the final product. Charles River Labs’ CEO James Foster is looking upstream to offer clients a faster “go/no go” indicator for preclinical work 05/01/2014 In this interview, James Foster discusses the recent acquisitions, future plans, changing R&D needs and market trends in preclinical outsourcing. James Foster Interview on Mad Money with Jim Cramer 03/21/2014 Mad Money host Jim Cramer speaks with James Foster on the Company’s turnaround and planned acquisition of the contract research division of Galapagos NV. What Charles River Labs' recent buys say about the future of biotech 03/14/2014 The area’s largest preclinical research organization just got a little larger with the acquisition of two European firms. But what CEO Jim Foster said about the reason for the acquisitions says a lot about both contract research organizations and where biotech in general is headed. DISPLAYING RESULTS 1-10 (OF 48) |< < 1 - 2 - 3 - 4 - 5 > >| Contact Us Our experts are available to answer any questions or discuss a quote. From: North America Europe Asia Other Call us at: 1.877.CRIVER.1 (1.877.274.8371) EMAIL US Careers Press Resources Investor Relations Legal Compliance Policies Connect with Us: RSS Twitter Facebook LinkedIn YouTube © 2021 Charles River Laboratories International, Inc. Legal Terms & Conditions Privacy Policy Safe Harbor Privacy Policy Products & Services Research Models & Services Discovery Services Preclinical Services Biologics Testing Solutions Endotoxin Detection & Microbial Identification Avian Vaccine Services Chemicals, Agro & Vet Therapeutic Areas Cardiovascular Central Nervous System Inflammation Metabolic Disease Musculoskeletal Disease Oncology Ophthalmology Respiratory Disease Contact Us Locations Initiate a Project News & Events What's New at Charles River Education & Training Eureka Science Community